TextMed
All Sources
TextMed
:
TextMap
:
Textblg
:
TextBiz
:
Make homepage!
:
Link to us
:
Help?
Relations for heparin
heparin Main Page
Entity 1
Relationship
Entity 2
Article
Frequency
Score
heparin
induced
thrombocytopenia
Complications of heparin therapy.
66
75.1962
warfarin
follow
heparin
Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.
34
69.0711
thrombocytopenia
complication
heparin
Heparin-associated thrombocytopenia.
7
39.8642
heparin
released-from
enzyme
Lipoprotein lipase: evidence for high- and low-affinity enzyme sites.
6
34.3523
danaparoid
replaced
heparin
Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
1
33.8033
heparin
compete-with
heparan
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.
1
33.5576
heparin
following
streptokinase
Australian multicentre trial of streptokinase in acute myocardial infarction.
5
33.5174
pentasaccharide
representing
heparin
Further characterization of the antithrombin-binding sequence in heparin.
2
33.4228
thrombolysis
superior
heparin
Thrombolytic therapy of non-cardiac disorders.
2
33.2243
heparinase
removed
heparin
Detection of HIV-1 RNA in heparinized plasma of HIV-1 seropositive individuals.
1
33.1792
disaccharide
derived-from
heparin
Diagnostic enzymology of alpha-L-iduronidase with special reference to a sulphated disaccharide derived from heparin.
2
32.2863
heparin
treatment
thromboembolism
[Contraceptive agents and thrombosis]
1
32.2804
heparin
derived-from
porcine
Thrombocytopenia found uncommonly during heparin therapy.
2
31.8824
heparin
release
lipase
Pulmonary macrophage: a major source of lipoprotein lipase in the lung.
2
31.4069
heparin
inhibitor
factor xia
SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor.
1
31.0503
sulfate
effective
heparin
Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.
1
30.9242
ticlopidine
superior
heparin
Current oral antiplatelet agents to prevent atherothrombosis.
1
30.8182
bradyarrhythmia
associated-with
heparin
Heparin-induced life-threatening hyperkalemia.
1
30.7012
heparin
associated
thrombocythemia
[Acute thrombosis of the right renal vein. Two cases with coagulopathies]
1
30.7012
heparin
not-associated-with
3-sulfate
Adverse effects of alkali and acid on the anticoagulant potency of heparin, evaluated with methyl 2-deoxy-2-sulfamino-alpha-D-glucopyranoside 3-sulfate as a model compound.
1
30.7012
heparin
associated-with
hypotension
[Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin]
1
30.7012
heparin
associated-with
hyperkalemia
Heparin-induced hyperkalemia.
1
30.7012
heparin
associated-with
ischemia
Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction.
1
30.7012
heparin
associated-with
respiratory distress syndrome
Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients.
1
30.7012
heparin
associated-with
osteoporotic
Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology.
1
30.7012
dipyridamole
follow
heparin
Consumption coagulopathy and microangiopathic hemolytic anemia with an axillo-femoral graft.
2
30.5174
acid
follow
heparin
LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.
2
30.5174
phenprocoumon
follow
heparin
Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion.
2
30.5174
heparin
release
lipoprotein lipase
Endothelin-1, but not endothelin-3, suppresses lipoprotein lipase gene expression in brown adipocytes differentiated in culture.
2
30.3523
lipoprotein lipase
responsible
heparin
Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis.
1
30.1808
thrombopenia
related-to
heparin
[Thrombopenia caused by heparin. Review of the literature apropos of a personal case]
2
30.0586
heparin
produce
fatty acids
The parallel effects of a very low molecular weight heparin (CY222) on anti Xa activity and thyroid hormone levels in blood.
2
29.9769
tetrasaccharide
derived-from
heparin
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
3
29.8947
priapism
occurring-during
heparin
Priapism: an unusual complication of heparin therapy for sudden deafness.
2
29.7744
heparin
cause
abnormalities
Hypothermia and bleeding during abdominal aortic aneurysm repair.
1
29.7013
heparin
not-cause
neutropenia
Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters.
1
29.7013
heparin
studied-in
pigs
The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
2
29.6074
heparin
developed
phlebitis
Use of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer.
1
29.5212
plasmapheresis
following
heparin
[Radioimmunodiagnosis in the correction of plasmapheresis methodology in thyrotoxicosis]
1
29.5174
ethyl alcohol
follow
heparin
Heparinized human umbilical vein grafts. Delayed heparin desorption after alcohol treatment.
1
29.5174
pulse methylprednisolone
follow
heparin
Renal amyloidosis associated with crescentic glomerulonephritis.
1
29.5174
4-hour
follow
heparin
Indium-111-labeled platelets: effects of heparin on uptake by venous thrombi and relationship to the activated partial thromboplastin time.
1
29.5174
heparin
following
deep vein thrombosis
[Should adjuvant treatments (antiplatelet agents, anticoagulants, normovolaemic haemodilution and vasodilators) be used in cervicofacial and maxillofacial free flaps reconstructive surgery?]
1
29.5174
myocardial infarction
include
heparin
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial.
1
29.4205
infection
include
heparin
Advances in parenteral nutrition.
1
29.4205
atheroma
include
heparin
The pathogenesis of atheroma and the rationale for its treatment.
1
29.4205
polypeptide
had
heparin
Structural comparisons of fibronectins isolated from early and late passage cells.
1
29.4103
heparin
had
hepatic artery thrombosis
Hepatic artery thrombosis after orthotopic liver transplantation.
1
29.4103
heparin
released
phospholipase
A heparin-sensitive phospholipase A2 and prostaglandin endoperoxide synthase-2 are functionally linked in the delayed phase of prostaglandin D2 generation in mouse bone marrow-derived mast cells.
1
29.3523
heparin
release
histaminase
Response of plasma histaminase activity to heparin in normal subjects and in patients with small cell carcinoma of the lung.
1
29.3523
About TextMed
:
TextMed Team
:
Disclaimer
:
Contact Us
Copyright (c) 2007 The Research Foundation of State University of New York
Computer Science Department
at
Stony Brook University